EXPLORER
DeviceTwo-week period with the robotics gait device for use in the natural settings deemed appropriate by the family.
NCT Number: NCT06765070
Neurodevelopmental disorders often lead to abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as an inability to stand and walk. EXPLORER is a robotic gait exoskeleton designed to rehabilitate children with motor disabilities in home and outdoor environments.
The aim of this study is to evaluate the efficacy and usability of EXPLORER in children with motor disability within their natural settings, including home and community environments.
This study is active but is not currently recruiting participants.
2 year–17 year
All sexes
Interventional
Not applicable
Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain
Neurodevelopmental disorders often lead to abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as an inability to stand and walk. Robotic devices are a useful tool in the rehabilitation of these children, but most of them are designed to be used in the clinical setting. EXPLORER is a robotic device designed to assist gait in children with motor disability in their homes and the community. The aim of this study is to evaluate the efficacy and usability of EXPLORER in children with motor disability within their natural settings, including home and community environments.
An initial session will be conducted in the participant's natural environment, during which the researchers will instruct the primary caregivers on the use of the device. Subsequently, the device will be left for a two-month period for use in the natural settings deemed appropriate by the family.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two-week period with the robotics gait device for use in the natural settings deemed appropriate by the family.
Time frame: through study completion, along 2 weeks
occurrence of any serious adverse event to the participant or the caregiver
Time frame: through study completion, along 2 weeks
Number of falling events occurred from the participant or caregiver
Time frame: through study completion, along 2 weeks
Occurrence of any injury of the skin in the areas of contact and produced by the use of the device
Time frame: through study completion, along 2 weeks
pain measured by the Visual Analogic Scale (VAS) by the participant and the caregiver, scored from 0 to 10, being 0 "no pain" and 10 "unbearable pain"
Time frame: through study completion, along 2 weeks
Time to don and doff the device to each participant
Time frame: through study completion, along 2 weeks
Time using the device
Time frame: through study completion, along 2 weeks
number of steps with the device
Time frame: through study completion, along 2 weeks
two different usage modes (active and automatic).
Time frame: through study completion, along 2 weeks
speed achieved with the device (steps per minute)
Time frame: through study completion, along 2 weeks
Environments where the device has been used and level of accessibility in each environment measured with a 5 points Likert scale (0 not accessible - 5 very accessible)
Time frame: Before starting the intervention (S1) and after completing the two weeks of use
Passive Degree to which a joint can move (hip, knee, and ankle joints in both legs). From 0º to 180º.
Time frame: Before starting the intervention (S1) and after completing the two weeks of use
Measured with the Child and Adolescent Scale of Participation. 20 ordinal scaled items across 4 subsections.
Maximum total score is 80 (20 items x 4) and the minimum total score is 20 (20 items x 1)
Time frame: at the end of the intervention
Using the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) questionnaire administered to the participants' caregivers at the end of the intervention. The QUEST 2.0 scale has 12 items. Each item is rated on a 5-point Likert scale
MarsiBionics
Industry
Efficacy and Usability of the EXPLORER Exoskeleton in Children With Neurodevelopmental Disorders in Their Natural Environment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07159360
Brain Damage, Chronic, Brain Diseases
Mexico City, Mexico
View Trial DetailsNCT07429188
Arthrogryposis, Central Nervous System Diseases
Perpignan, France
View Trial DetailsNCT06970522
Motor Development, Muscle Tone
Chicago, Illinois, United States
View Trial DetailsNCT07437378
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy (DMD)
Minya, Menia Governorate, Egypt
View Trial Details